Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs Unfractionated Heparin in PCI
NCT00439855Phase 4Completed
- Sponsor
- Stadtspital Zürich Triemli
- Start
- Sep 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in coronary artery disease (CAD), sponsored by Stadtspital Zürich Triemli. Started Sep 2003; status: completed.
02
Drugs
enoxaparin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00439855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439855.